Metabolic, Endocrine and GI

• Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literature.

  Date: 1-1-2006  |  Category: Metabolic, Endocrine and GI
  Stephens JM, Botteman MF, Hay JW. J Manag Care Pharm 2006;12(2):130-142.

  ---

• Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication.

  Date: 1-1-2006  |  Category: Metabolic, Endocrine and GI
  Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de Jong HG, Broeders IA, Gooszen HG. Br J Surg. 2006;93(6):690-7.

  ---

• Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy?

  Date: 1-1-2005  |  Category: Metabolic, Endocrine and GI
  Venneman NG, Buskens E, Besselink MG, Stads S, Go PM, Bosscha K, van Berge-Henegouwen GP, van Erpecum KJ. Am J Gastroenterol. 2005;100(11):2540-50.

  ---

• Results and Complications after Ileal Pouch Anal Anastomosis: A Meta-Analysis of 43 Observational Studies Comprising 9,317 Patients.

  Date: 1-1-2005  |  Category: Metabolic, Endocrine and GI
  Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJ. Dig Surg. 2005;22(1-2):69-79.

  ---

• More chances to anticipate on risk factors: Rhabdomyolysis as adverse event of statins.

  Date: 1-1-2004  |  Category: Metabolic, Endocrine and GI
  Verheggen BG, Bocxe JTH, Bergsma R, Schellens JHM. Pharm Weekbl 2004;139(24):836-840.

  ---

• Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

  Date: 1-1-2003  |  Category: Metabolic, Endocrine and GI
  Klok RM, Postma MJ, van Hout BA, Brouwers JR. Aliment Pharmacol Ther. 2003;17(10):1237-45.

  ---

• A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.

  Date: 1-1-2003  |  Category: Metabolic, Endocrine and GI
  van Hout BA, Klok RM, Brouwers JR, Postma MJ. Clin Ther. 2003;25(2):635-46.

  ---

• Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.

  Date: 1-1-2003  |  Category: Metabolic, Endocrine and GI
  Ramsdell JW, Braunstein SN, Stephens JM, Bell CF, Botteman MF, Devine ST. Pharmacoeconomics. 2003;21(11):819-37.

  ---

• Persistence patterns with oral hypoglycemic agents in type 2 diabetes.

  Date: 1-1-2002  |  Category: Metabolic, Endocrine and GI
  Stephens JM, Blak BT, Gold KF, Botteman MF, Pashos CL, Walkinshaw CS, Campbell RK. J Clin Outcomes Man 2002; 9(9):491-499.

  ---

• Quality of life of patients with Fabry disease.

  Date: 1-1-2002  |  Category: Metabolic, Endocrine and GI
  Gold KF, Pastores GM, Botteman MF, Yeh JM, Sweeney S, Aliski W, Pashos CL. Qual Life Res. 2002;11(4):317-27.

  ---